These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23251633)

  • 21. Insulin acts as an atypical KCNQ1/KCNE1-current activator and reverses long QT in insulin-resistant aged rats by accelerating the ventricular action potential repolarization through affecting the β
    Olgar Y; Durak A; Bitirim CV; Tuncay E; Turan B
    J Cell Physiol; 2022 Feb; 237(2):1353-1371. PubMed ID: 34632595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel mutation in KCNQ1 associated with a potent dominant negative effect as the basis for the LQT1 form of the long QT syndrome.
    Aizawa Y; Ueda K; Scornik F; Cordeiro JM; Wu Y; Desai M; Guerchicoff A; Nagata Y; Iesaka Y; Kimura A; Hiraoka M; Antzelevitch C
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):972-7. PubMed ID: 17655673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trafficking-deficient long QT syndrome mutation KCNQ1-T587M confers severe clinical phenotype by impairment of KCNH2 membrane localization: evidence for clinically significant IKr-IKs alpha-subunit interaction.
    Biliczki P; Girmatsion Z; Brandes RP; Harenkamp S; Pitard B; Charpentier F; Hébert TE; Hohnloser SH; Baró I; Nattel S; Ehrlich JR
    Heart Rhythm; 2009 Dec; 6(12):1792-801. PubMed ID: 19959132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long QT syndrome-associated mutations in KCNQ1 and KCNE1 subunits disrupt normal endosomal recycling of IKs channels.
    Seebohm G; Strutz-Seebohm N; Ureche ON; Henrion U; Baltaev R; Mack AF; Korniychuk G; Steinke K; Tapken D; Pfeufer A; Kääb S; Bucci C; Attali B; Merot J; Tavare JM; Hoppe UC; Sanguinetti MC; Lang F
    Circ Res; 2008 Dec; 103(12):1451-7. PubMed ID: 19008479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allosteric mechanism for KCNE1 modulation of KCNQ1 potassium channel activation.
    Kuenze G; Vanoye CG; Desai RR; Adusumilli S; Brewer KR; Woods H; McDonald EF; Sanders CR; George AL; Meiler J
    Elife; 2020 Oct; 9():. PubMed ID: 33095155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of abnormal trafficking of KCNE1 in long QT syndrome 5.
    Harmer SC; Tinker A
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1074-6. PubMed ID: 17956282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic modulation of KCNQ1/KCNE1 K(+) channels (IKs) by phosphatidylinositol 4,5-bisphosphate (PIP2) and [ATP]i.
    Kienitz MC; Vladimirova D
    Cell Signal; 2015 Jul; 27(7):1457-68. PubMed ID: 25892084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population.
    Liu W; Yang J; Hu D; Kang C; Li C; Zhang S; Li P; Chen Z; Qin X; Ying K; Li Y; Li Y; Li Z; Cheng X; Li L; Qi Y; Chen S; Wang Q
    Hum Mutat; 2002 Dec; 20(6):475-6. PubMed ID: 12442276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Kv7.1-phosphatidylinositol 4,5-bisphosphate interaction sites uncovered by charge neutralization scanning.
    Eckey K; Wrobel E; Strutz-Seebohm N; Pott L; Schmitt N; Seebohm G
    J Biol Chem; 2014 Aug; 289(33):22749-22758. PubMed ID: 24947509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and coassociation of ERG1, KCNQ1, and KCNE1 potassium channel proteins in horse heart.
    Finley MR; Li Y; Hua F; Lillich J; Mitchell KE; Ganta S; Gilmour RF; Freeman LC
    Am J Physiol Heart Circ Physiol; 2002 Jul; 283(1):H126-38. PubMed ID: 12063283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical and functional interaction sites in cytoplasmic domains of KCNQ1 and KCNE1 channel subunits.
    Chen J; Liu Z; Creagh J; Zheng R; McDonald TV
    Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H212-H222. PubMed ID: 31834838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocannabinoids enhance hK
    Hiniesto-Iñigo I; Castro-Gonzalez LM; Corradi V; Skarsfeldt MA; Yazdi S; Lundholm S; Nikesjö J; Noskov SY; Bentzen BH; Tieleman DP; Liin SI
    EBioMedicine; 2023 Mar; 89():104459. PubMed ID: 36796231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome.
    Ohno S; Toyoda F; Zankov DP; Yoshida H; Makiyama T; Tsuji K; Honda T; Obayashi K; Ueyama H; Shimizu W; Miyamoto Y; Kamakura S; Matsuura H; Kita T; Horie M
    Hum Mutat; 2009 Apr; 30(4):557-63. PubMed ID: 19306396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic partnership between KCNQ1 and KCNE1 and influence on cardiac IKs current amplitude by KCNE2.
    Jiang M; Xu X; Wang Y; Toyoda F; Liu XS; Zhang M; Robinson RB; Tseng GN
    J Biol Chem; 2009 Jun; 284(24):16452-16462. PubMed ID: 19372218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Action potential clamp and mefloquine sensitivity of recombinant 'I KS' channels incorporating the V307L KCNQ1 mutation.
    El Harchi A; McPate MJ; Zhang YH; Zhang H; Hancox JC
    J Physiol Pharmacol; 2010 Apr; 61(2):123-31. PubMed ID: 20436212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biophysical properties of mutant KCNQ1 S277L channels linked to hereditary long QT syndrome with phenotypic variability.
    Aidery P; Kisselbach J; Schweizer PA; Becker R; Katus HA; Thomas D
    Biochim Biophys Acta; 2011 Apr; 1812(4):488-94. PubMed ID: 21241800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid hormone receptor alpha can control action potential duration in mouse ventricular myocytes through the KCNE1 ion channel subunit.
    Mansén A; Tiselius C; Sand P; Fauconnier J; Westerblad H; Rydqvist B; Vennström B
    Acta Physiol (Oxf); 2010 Feb; 198(2):133-42. PubMed ID: 19832729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KCNE1 enhances phosphatidylinositol 4,5-bisphosphate (PIP2) sensitivity of IKs to modulate channel activity.
    Li Y; Zaydman MA; Wu D; Shi J; Guan M; Virgin-Downey B; Cui J
    Proc Natl Acad Sci U S A; 2011 May; 108(22):9095-100. PubMed ID: 21576493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KCNE2 is colocalized with KCNQ1 and KCNE1 in cardiac myocytes and may function as a negative modulator of I(Ks) current amplitude in the heart.
    Wu DM; Jiang M; Zhang M; Liu XS; Korolkova YV; Tseng GN
    Heart Rhythm; 2006 Dec; 3(12):1469-80. PubMed ID: 17161791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BACE1 modulates gating of KCNQ1 (Kv7.1) and cardiac delayed rectifier KCNQ1/KCNE1 (IKs).
    Agsten M; Hessler S; Lehnert S; Volk T; Rittger A; Hartmann S; Raab C; Kim DY; Groemer TW; Schwake M; Alzheimer C; Huth T
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):335-48. PubMed ID: 26454161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.